Log in to save to my catalogue

Nitrous oxide (N 2 O) and subsequent open-label SSRI treatment of adolescents with depression (NOTAD...

Nitrous oxide (N 2 O) and subsequent open-label SSRI treatment of adolescents with depression (NOTAD...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_72f9e2742ffc4e189e8ac828b67426c0

Nitrous oxide (N 2 O) and subsequent open-label SSRI treatment of adolescents with depression (NOTAD): study protocol for a randomised controlled trial

About this item

Full title

Nitrous oxide (N 2 O) and subsequent open-label SSRI treatment of adolescents with depression (NOTAD): study protocol for a randomised controlled trial

Publisher

England: BioMed Central

Journal title

Current controlled trials in cardiovascular medicine, 2017-12, Vol.18 (1), p.617-617, Article 617

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

The first line of pharmacological treatment for severe depressive disorders in young people is selective serotonin reuptake inhibitors (SSRIs). However, beneficial clinical effects are rarely observed before several weeks into treatment. Nitrous oxide (N
O) has a long-standing safety record for pain relief and has been used in adults and young p...

Alternative Titles

Full title

Nitrous oxide (N 2 O) and subsequent open-label SSRI treatment of adolescents with depression (NOTAD): study protocol for a randomised controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_72f9e2742ffc4e189e8ac828b67426c0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_72f9e2742ffc4e189e8ac828b67426c0

Other Identifiers

ISSN

1745-6215

E-ISSN

1745-6215

DOI

10.1186/s13063-017-2342-4

How to access this item